EcoDrugPlus

Monoamine Oxidase A

Ensembl ID : ENSMLUG00000001427
Gene Symbol: MAOA
2 Cross references
146 Possible Orthologues:

Monoamine Oxidase B

Ensembl ID : ENSMLUG00000001434
Gene Symbol: MAOB
2 Cross references
330 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSMLUG00000017152
Gene Symbol: MGLL
2 Cross references
208 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSMLUG00000006092
Gene Symbol: MPO
4 Cross references
181 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSMLUG00000001852
Gene Symbol: NPR1
2 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSMLUG00000011640
Gene Symbol: NPR2
4 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSMLUG00000013695
Gene Symbol: NPR3
2 Cross references
211 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSMLUG00000010894
Gene Symbol: NPY2R
2 Cross references
246 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSMLUG00000012044
Gene Symbol: NPY5R
2 Cross references
135 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSMLUG00000010479
Gene Symbol: NTRK1
2 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSMLUG00000016765
Gene Symbol: NTRK2
2 Cross references
286 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSMLUG00000008897
Gene Symbol: NTRK3
2 Cross references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).